Madrigal Pharmaceuticals, Inc. (MDGL)

571.44 +0.11 (+0.02%) USD  |  NASDAQ  |  Dec 12, 16:00
580.49 +9.05 (+1.58%) After-Hours: 20:00
More

Madrigal Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Amgen, Inc. --
Alnylam Pharmaceuticals, Inc. --
Amicus Therapeutics, Inc. --
Insmed, Inc. --
Ionis Pharmaceuticals, Inc. --